Papers: 10.1016/j.chembiol.2018.07.013

https://doi.org/10.1016/j.chembiol.2018.07.013

Combining Mutational Signatures, Clonal Fitness, and Drug Affinity to Define Drug-Specific Resistance Mutations in Cancer

Cited by: 14
Author(s): Teresa Kaserer, Julian Blagg
Published: almost 8 years ago

Software Mentions 1